Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

813.00INR
2:20pm IST
Change (% chg)

Rs-12.50 (-1.51%)
Prev Close
Rs825.50
Open
Rs831.00
Day's High
Rs842.05
Day's Low
Rs808.55
Volume
364,414
Avg. Vol
591,294
52-wk High
Rs965.15
52-wk Low
Rs706.40

SUN.BO

Chart for SUN.BO

About

Sun Pharmaceutical Industries Limited is an India-based generic and pharmaceutical company. The Company's business segments include US Business, which includes Western Europe, Canada, Australia, New Zealand and Other Markets; Indian Branded Generics Business, including Global Consumer Healthcare Business, and Emerging Markets,... (more)

Overall

Beta: 0.33
Market Cap(Mil.): Rs1,985,452.00
Shares Outstanding(Mil.): 2,406.75
Dividend: 3.00
Yield (%): 0.36

Financials

  SUN.BO Industry Sector
P/E (TTM): 49.16 35.22 36.14
EPS (TTM): 16.78 -- --
ROI: -- 13.74 13.10
ROE: -- 14.88 14.37

BUZZ-India's Sun Pharma drops; gets U.S. subpoena on generic drug pricing

** India's largest drugmaker says it received a subpoena from the U.S. Department of Justice seeking information about the pricing and marketing of generic drugs it sells in the country

10:57am IST

BUZZ-India's Sun Pharma gains on deal to buy Novartis Japan brands

** India's Sun Pharmaceuticals rises as much as 2.44 pct, set to close higher after two straight days of losses

30 Mar 2016

Sensex posts biggest fall in five weeks

MUMBAI Indian stocks fell more than 1 percent on Monday, posting their biggest single-day fall in five weeks, as investors booked profit in recent outperformers ahead of a busy week of events, including the expiry of domestic derivative contracts.

28 Mar 2016

Indian shares fall 1 pct; metals, drugmakers drag

MUMBAI, March 28 Indian shares fell 1 percent on Monday as investors booked profit in recent outperformers such as State Bank of India and Hindalco Industries ahead of a busy week of events, including the release of U.S. economic data and the expiry of domestic derivative contracts.

28 Mar 2016

BRIEF-Sun Pharma says not looking for external assets as of now

* Dilip Shanghvi says not looking for external assets as of now Further company coverage:

12 Feb 2016

India's largest drugmaker Sun Pharma's Q3 profit beats estimates

MUMBAI, Feb 12 India's largest drugmaker, Sun Pharmaceutical Industries Ltd, reported a third-quarter net profit outpacing analysts' estimates, lifting its shares up as much as 6.5 percent.

12 Feb 2016

BUZZ-India's Sun Pharma may miss profit estimates - StarMine

** India's Sun Pharmaceutical Industries Ltd falls as much as 3.37 pct

12 Feb 2016

BUZZ-India's Sun Pharma gains as Kotak says FDA warning issues not major

** Shares in India's Sun Pharmaceuticals Industries Ltd rose as much as 3.4 percent on Wednesday morning to a high of 790 rupees

23 Dec 2015

Earnings vs. Estimates